In Vitro Antitumor Evaluation of Some Hybrid Molecules Containing Coumarin and Quinolinone Moieties

Abstract

Background: Hybrid molecules furnished by merging two or more pharmacophores is an emerging concept in the field of medicinal chemistry and drug discovery. Currently, coumarin hybrids have attracted the keen attention of researchers to discover their therapeutic capability against cancer. Objective: The present study aimed to evaluate the in vitro antitumor activity of a new series of hybrid molecules containing coumarin and quinolinone moieties 4 and 5 against four cancer cell lines. Materials and Methods: A new series of hybrid molecules containing coumarin and quinolinone moieties, 4a-c and 5a-c, were synthesized and screened for their cytotoxicity against prostate PC-3, breast MCF-7, colon HCT- 116 and liver HepG2 cancer cell lines as well as normal breast Hs-371 T. Results: All the synthesized compounds were assessed for their in vitro antiproliferative activity against four cancer cell lines and several compounds were found to be active. Further in vitro cell cycle study of compounds 4a and 5a revealed MCF-7 cells arrest at G2 /M phase of the cell cycle profile and induction apoptosis at pre-G1 phase. The apoptosis-inducing activity was evidenced by up-regulation of Bax protein together with the downregulation of the expression of Bcl-2 protein. The mechanism of cytotoxic activity of compounds 4a and 5a correlated to its topoisomerase II inhibitory activity. Conclusion: Hybrid molecules containing coumarin and quinolinone moieties represents a scaffold for further optimization to obtain promising anticancer agents.

Design, synthesis, and cytotoxicity screening of new synthesized imidazolidine‐2‐thiones as VEGFR‐2 enzyme inhibitors

“…Acetylation and alkylation of compound 3 with acetic anhydride and methyl iodide resulted in the formation of ethyl 3‐(4‐acetoxy phenyl)‐2‐cyano‐3‐[4‐hydroxy‐3‐(3‐phenylallylidene)amino‐2‐thioxo‐2,3‐dihydro‐1 H ‐imidazol‐1‐yl]acrylate ( 4 ) and ethyl 2‐cyano‐3‐[4‐hydroxy‐3‐(3‐phenylallylidene)amino‐2‐thioxo‐2,3‐dihydro‐1 H ‐imidazol‐1‐yl]‐3‐(4‐methoxyphenyl)acrylate ( 5 ), respectively [ 19 ] (Scheme 2).…”

“…. [18] Acetylation and alkylation of compound (3-phenylallylidene)amino-2-thioxo-2,3-dihydro-1H-imidazol-1-yl]-3-(4methoxyphenyl)acrylate (5), respectively [19] (Scheme 2). amino]-2-thioxoimidazolidin-4-one (7) (Scheme 3).…”